NOC Stock Analysis: Northrop Grumman | NYSE
Aerospace & Defense | NYSE, USA | Market Cap: 68.474m USD | 12M Return: -22.8% | US6668071029 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 452M
EPS Trend: 73.3%
Qual. Beats: 0
Rev. Trend: 90.0%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Northrop Grumman Corporation (NYSE: NOC) is a U.S.-headquartered aerospace and defense technology company that operates across four business segments: Aeronautics Systems, Defense Systems, Mission Systems, and Space Systems. Its portfolio spans military aircraft, autonomous and unmanned systems, missile defense, strategic deterrent systems, C4ISR (command, control, communications, computers, intelligence, surveillance, and reconnaissance) solutions, electronic warfare, and satellites and space systems. The company serves customers in the United States, Asia/Pacific, Europe, and other international markets, and was founded in 1939 with its headquarters in Falls Church, Virginia.
The company sits within the GICS Industrials sector under the Aerospace & Defense sub-industry, a segment characterized by long product development cycles and heavy reliance on government defense and intelligence contracts. Northrop Grummans four-segment structure reflects the major capability domains typical of large prime defense contractors: air, land/sea-based weapons and missile defense, networked mission and electronic systems, and space-based assets and launch.
- B-21 Raider production ramp accelerates Aeronautics Systems revenue
- Sentinel ICBM cost overruns pressure Defense Systems margins
- Space Systems backlog expands on missile defense demand
| Net Income: 4.50b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 4.54 > 1.0 |
| NWC/Revenue: 5.23% < 20% (prev 0.97%; Δ 4.27% < -1%) |
| CFO/TA 0.10 > 3% & CFO 5.08b > Net Income 4.50b |
| Net Debt (15.8b) to EBITDA (7.44b): 2.13 < 3 |
| Current Ratio: 1.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (142.4m) vs 12m ago -1.11% < -2% |
| Gross Margin: 20.06% > 18% (prev 19.33%; Δ 0.73% > 0.5%) |
| Asset Turnover: 85.60% > 50% (prev 81.90%; Δ 3.70% > 0%) |
| Interest Coverage Ratio: 8.98 > 6 (EBIT TTM 5.92b / Interest Expense TTM 659.0m) |
| A: 0.04 (Total Current Assets 15.6b - Total Current Liabilities 13.3b) / Total Assets 50.8b |
| B: 0.35 (Retained Earnings 17.8b / Total Assets 50.8b) |
| C: 0.12 (EBIT TTM 5.92b / Avg Total Assets 50.1b) |
| D: 0.54 (Book Value of Equity 17.9b / Total Liabilities 32.9b) |
| Altman-Z'' = 2.80 = A |
| DSRI: 1.04 (Receivables 10.3b/9.33b, Revenue 42.9b/40.5b) |
| GMI: 0.96 (GM 19.33% / 20.06%) |
| AQI: 0.96 (AQ_t 0.45 / AQ_t-1 0.47) |
| SGI: 1.06 (Revenue 42.9b / 40.5b) |
| TATA: -0.01 (NI 4.50b - CFO 5.08b) / TA 50.8b) |
| Beneish M = -3.01 (Cap -4..+1) = AA |
As of October 09, 2026, the stock is trading at USD 484.48 with a total of 1,087,146 shares traded. Over the past week, the price has changed by +0.51%, over one month by -6.58%, over three months by -10.72% and over the past year by -22.82%.
Current recommended Stop Loss: 470.60 (which is 2.9% or 1.2 ATR below the current price).
Northrop Grumman has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy NOC.
- StrongBuy: 10
- Buy: 4
- Hold: 10
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 644.5 | 33% |
P/E Trailing = 15.3601
P/E Forward = 17.0358
P/S = 1.5964
P/B = 4.0863
P/EG = 3.4068
Revenue TTM = 42.9b USD
EBIT TTM = 5.92b USD
EBITDA TTM = 7.44b USD
Long Term Debt = 14.4b USD (from longTermDebt, last quarter)
Short Term Debt = 865.0m USD (from shortTermDebt, last fiscal year)
Debt = 18.1b USD (from shortLongTermDebtTotal, last quarter) + Leases 1.86b
Net Debt = 15.8b USD (calculated: Debt 18.1b - CCE 2.31b)
Enterprise Value = 84.3b USD (68.5b + Debt 18.1b - CCE 2.31b)
Interest Coverage Ratio = 8.98 (Ebit TTM 5.92b / Interest Expense TTM 659.0m)
EV/FCF = 23.13x (Enterprise Value 84.3b / FCF TTM 3.65b)
FCF Yield = 4.32% (FCF TTM 3.65b / Enterprise Value 84.3b)
FCF Margin = 8.50% (FCF TTM 3.65b / Revenue TTM 42.9b)
Net Margin = 10.48% (Net Income TTM 4.50b / Revenue TTM 42.9b)
Gross Margin = 20.06% ((Revenue TTM 42.9b - Cost of Revenue TTM 34.3b) / Revenue TTM)
Gross Margin QoQ = 19.50% (prev 19.84%)
Tobins Q-Ratio = 1.66 (Enterprise Value 84.3b / Total Assets 50.8b)
Interest Expense / Debt = 3.63% (Interest Expense 659.0m / Debt 18.1b)
Taxrate = 14.54% (765.0m / 5.26b)
NOPAT = 5.06b (EBIT 5.92b * (1 - 14.54%))
Current Ratio = 1.17 (Total Current Assets 15.6b / Total Current Liabilities 13.3b)
Debt / Equity = 1.01 (Debt 18.1b / totalStockholderEquity, last quarter 17.9b)
Debt / EBITDA = 2.13 (Net Debt 15.8b / EBITDA 7.44b)
Debt / FCF = 4.35 (Net Debt 15.8b / FCF TTM 3.65b)
Total Stockholder Equity = 16.9b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.97% (Net Income 4.50b / Total Assets 50.8b)
RoE = 26.58% (Net Income TTM 4.50b / Total Stockholder Equity 16.9b)
RoCE = 18.89% (EBIT 5.92b / Capital Employed (Equity 16.9b + L.T.Debt 14.4b))
RoIC = 14.00% (NOPAT 5.06b / Invested Capital 36.1b)
WACC = 4.89% (E(68.5b)/V(86.6b) * Re(5.36%) + D(18.1b)/V(86.6b) * Rd(3.63%) * (1-Tc(0.15)))
Discount Rate = 5.36% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.57 | Cagr: -2.08%
[DCF] Terminal Value 77.97% ; FCFF base≈2.71b ; Y1≈3.11b ; Y5≈4.57b
[DCF] Fair Price = 372.9 (EV 68.8b - Net Debt 15.8b = Equity 53.0b / Shares 142.1m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 73.31 | EPS CAGR: 6.09% | SUE: 0.62 | # QB: 0
Revenue Correlation: 90.03 | Revenue CAGR: 2.97% | SUE: 0.27 | # QB: 0
EPS current Quarter (2026-09-30): EPS=7.17 | Chg30d=+0.11% | Revisions=+63% | Analysts=18
EPS current Year (2026-12-31): EPS=29.01 | Chg30d=+0.04% | Revisions=+88% | GrowthEPS=+10.1% | GrowthRev=+5.0%
EPS next Year (2027-12-31): EPS=30.45 | Chg30d=+0.04% | Revisions=+57% | GrowthEPS=+5.0% | GrowthRev=+6.7%
[Analyst] Revisions Ratio: +78% (up=50, down=5)